Stay updated with breaking news from Negative Predictive. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker findings from the company's...
Get information about developing evidence-based articles, including an EBM glossary, AFP's rating system, and links to additional resources.
Skip to main content Currently Reading Diagnostic to Manage Benign vs. Malignant Adrenal Tumors with 100% Negative Predictive Certainty presented via Hidden GEMS Program from One Million Solutions in Health PRWeb FacebookTwitterEmail Through its Hidden GEMS Program and this science developed by the NIH, One Million Solutions in Health offers the chance to learn about licensing a three-pronged diagnostic that could 'change the game' when it comes to adrenal tumor diagnosis and treatment, while combating the prevalence of potentially unnecessary surgeries. Boston, Massachusetts (PRWEB) January ...